Idera Pharmaceuticals (IDRA) Stock: Headed Up On Update

Idera Pharmaceuticals Inc (NASDAQ: IDRA) is having an incredibly strong start to the trading session this morning, and for good reason. The company updated investors with regard to the company’s strategy this morning, following the news surrounding the termination of the proposed merger with BioCryst Pharmaceuticals. Today, we’ll talk about: The update; what we’re seeing … Read more

Idera Pharmaceuticals (IDRA) Stock: Diving On Failed Clinical Trial

Idera Pharmaceuticals Inc (NASDAQ: IDRA) is having an overwhelmingly rough start to the trading session this mroning after the company announced top-line data from a Phase 2 clinical trial. Unfortunatley, the trial proved to be a failure, leading to fear among investors and sending the stock spiraling downward. Today, we’ll talk about: The clinical results; … Read more

Idera Pharmaceuticals (IDRA) Stock: Gaining On 2018 Update And Outlook

Idera Pharmaceuticals Inc (NASDAQ: IDRA) is having an overwhelmingly strong day in the market today, and for good reason. The company issued a press release this morning, providing investors with an update with regard to both clinical development and corporate activities. Today, we’ll talk about the update, what we’re seeing from the stock, and what … Read more

Idera Pharmaceuticals (IDRA) Stock: Gaining On Fast Track Designation

Idera Pharmaceuticals Inc (NASDAQ: IDRA) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that it has received Fast Track Designation from the United States Food and Drug Association. Today, we’ll talk about the news, how the stock reacted, and what we’ll be watching for … Read more

Idera Pharmaceuticals (IDRA) Stock: Gains On Clinical Advancement

Idera Pharmaceuticals Inc (NASDAQ: IDRA) is having an incredible start to the trading session today, and for good reason. The company provided an update with regard to one of the therapies that it is currently investigating, leading to excitement among investors and gains in the stock. As is almost always the case, our partners at … Read more

Idera Pharmaceuticals (IDRA) Stock: Gains Big On JPM Securities Coverage

Idera Pharmaceuticals Inc (NASDAQ: IDRA) Idera Pharmaceuticals is having an incredible day in the market today. The movement in the stock is driven by news that JPM securities has initiated coverage on the stock, and they have a positive view overall. As a result of the news, the stock spiked, causing our partners at Trade … Read more

Biotech Stocks For The Opportunists | Idera Pharmaceuticals (IDRA) | MannKind Corporation (MNKD) | Neurometrix (NURO)

Looking into the biotech market today, things aren’t looking too great. Nonetheless, there are still several opportunities that are popping up. Today, we’ll talk about 3 stocks I’ve found in biotech that seem to be presenting strong opportunities for growth. So, let’s get right to it… Idera Pharmaceuticals Stock Climbs On New Coverage Idera Pharmaceuticals … Read more

01:50PM Trade Buzz – Dollar General Corp. (NYSE:DG), EnteroMedics Inc (NASDAQ:ETRM), AOL, Inc.(NYSE:AOL), Idera Pharmaceuticals Inc (NASDAQ:IDRA)

On Friday, in the course of current trade, Shares of Dollar General Corp. (NYSE:DG), dropped -0.48%, and is now trading at $72.75. Dollar General, declared that the Company’s Board of Directors has declared a regular quarterly cash dividend of $0.22 per share on the Company’s common stock. The dividend will be payable on July 1, … Read more